Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by GrahamBon May 27, 2021 8:54pm
291 Views
Post# 33283665

RE:RE:RE:RE:GE healthcare and reconstruction with AI

RE:RE:RE:RE:GE healthcare and reconstruction with AI

Good points.

To me-I also see VPTs ultrasound to be an adjunct to the MRI, if I understood you correctly.
 

It does offer portability and cost effectiveness as you note.
 

To me, and from discussions with radiologists (not cardiologists) MRI is a superior technique for resolution  at a tissue level but CT is preferred depending on what you are examining(bones,lung, viscera) and quicker.

Ultrasound has the advantages you mention but doesn’t have the resolution of the other 2 techniques.
 

Most hospitals already have CTs and MRIs so the AI application should be an easy add on. I was impressed how quickly this is advancing since I last researched it.

 

To me-smaller clinics could really be the market for VPTs device -and the leasing model you mentioned makes sense

 

Anyway, with vaccinations rates increasing, and infection rates starting to subside,hopefully VPT can get access to clinics and we can see how this plays out

 

The margins will be important to see- the gross  margins  were not 95%(more like 50%) and on net were a loss.
 

So should be interesting to see the new data for sure on financials.
 

Ok

Time to watch some playoff sports and have a IPA

Good to discuss rationally.

<< Previous
Bullboard Posts
Next >>